Clinical advances in therapies targeting the interleukin‐2 receptor

Saved in:
Bibliographic Details
Published inQJM : An International Journal of Medicine Vol. 96; no. 2; pp. 91 - 102
Main Author CHURCH, A. C
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.02.2003
Oxford Publishing Limited (England)
Subjects
Animals
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Autoimmune Diseases - drug therapy
Basiliximab
Biological and medical sciences
Daclizumab
Fundamental and applied biological sciences. Psychology
General aspects
Graft Rejection - drug therapy
Humans
Immunoglobulin G - therapeutic use
Immunosuppressive Agents - therapeutic use
Interleukin-2 - chemistry
Interleukin-2 - therapeutic use
Mice
Mice, Knockout
Molecular and cellular biology
Neoplasms - drug therapy
Receptors, Interleukin-2 - chemistry
Receptors, Interleukin-2 - immunology
Receptors, Interleukin-2 - physiology
Recombinant Fusion Proteins
Signal Transduction
Autoimmunity
Human
Interleukin 2
Antibody
Surgery
Cytokine
Chemical mediator
Malignancy
Transplantation
Molecular biology
Biological receptor
Online AccessGet full text

Cover

More Information
Bibliography:local:960091
istex:223683666991C358D694B05EDEE33280F6C4458A
PII:1460-2393
ark:/67375/HXZ-WK5B7NKL-2
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1460-2725
1460-2393
1460-2393
DOI:10.1093/qjmed/hcg014